CatalystWireBeta

Niox Group (NIOX): NIOX PRO device rollout

This situation live

NIOX Niox Group

£286m · 68.8p · +0% since the first step
70.0p 54.4p Now 68.8p · 23 Oct −10% +3% +11% +1% Jan ’26FebMarAprMayJunJulAugSepOct
20 Jan 2026 · Launched; first sale December 2025 · −10% until the next step Successfully introduced the new next-generation NIOX PRO® device, with the first sale in December 2025.
24 Mar 2026 · Launched; first sale December 2025; approvals pending · +3% until the next step Market-by-market regulatory approvals will occur throughout 2026.
28 Jul 2026 · CE Mark and MHRA obtained; US/Japan pending · +11% until the next step CE Mark and UK MHRA approval obtained for NIOX PRO®. US and Japan approvals expected during H2 2026.
29 Sep 2026 · CE/MHRA rollout begun; US, Japan submissions progressing · +1% since Regulatory submissions for NIOX PRO® continue to progress in the US and Japan.
Project milestones
NIOX PRO device rollout
CE/MHRA rollout begun; US, Japan submissions progressing
Next: US and Japan regulatory approvals for NIOX PRO
Every step · 4
  1. 20 Jan 2026 Launched; first sale December 2025 – Successfully introduced the new next-generation NIOX PRO® device, with the first sale in December 2025. ↗
  2. 24 Mar 2026 Launched; first sale December 2025; approvals pending – Market-by-market regulatory approvals will occur throughout 2026. ↗
  3. 28 Jul 2026 CE Mark and MHRA obtained; US/Japan pending – CE Mark and UK MHRA approval obtained for NIOX PRO®. US and Japan approvals expected during H2 2026. ↗
  4. 29 Sep 2026 CE/MHRA rollout begun; US, Japan submissions progressing – Regulatory submissions for NIOX PRO® continue to progress in the US and Japan. ↗

What is happening

Niox Group: NIOX PRO device rollout – CE/MHRA rollout begun; US, Japan submissions progressing. ['CE/MHRA rollout begun; US, Japan submissions progressing']

Announced
20 Jan 2026 · Launched; first sale December 2025
Latest
29 Sep 2026 · CE/MHRA rollout begun; US, Japan submissions progressing
What it changes
The July capital-return intention becomes a £12.5m tender, while H1 weakness and the full-year consensus guide still depend on a stronger H2 from NIOX PRO, Japan pricing and deferred demand.

What comes next

US and Japan regulatory approvals for NIOX PRO.

Ask NIOX Beta
Ask anything about Niox Group

Answered from its own announcements and reported figures, every statement linked to its source.

From the company's own announcements. Not investment advice.

Briefing Pro

New to Niox Group? Get up to speed in 2 minutes.

What it does, how it got here, what management promised and delivered – written from its own announcements.

Get the NIOX briefing →
Also at Niox Group 0 open
Capital returnTender offer – paid · closed Takeover targetOffer for the company – offer · closed Insider conviction1 director buying – £25k in 1 buy · closed Insider conviction2 directors buying – £67k in 2 buys · closed Niox Group – company page →

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note